Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız:
http://hdl.handle.net/11452/23043
Tüm üstveri kaydı
Dublin Core Alanı | Değer | Dil |
---|---|---|
dc.date.accessioned | 2021-12-07T11:11:14Z | - |
dc.date.available | 2021-12-07T11:11:14Z | - |
dc.date.issued | 2009-04 | - |
dc.identifier.citation | Yalçın, M. ve Aydın, C. (2009). "Cardiovascular effects of centrally administered arachidonic acid in haemorrhage-induced hypotensive rats: Investigation of a peripheral mechanism". Clinical and Experimental Pharmacology and Physiology, 36(4), 447-453. | en_US |
dc.identifier.issn | 1440-1681 | - |
dc.identifier.uri | https://doi.org/10.1111/j.1440-1681.2008.05087.x | - |
dc.identifier.uri | https://onlinelibrary.wiley.com/doi/10.1111/j.1440-1681.2008.05087.x | - |
dc.identifier.uri | http://hdl.handle.net/11452/23043 | - |
dc.description.abstract | 1. The aims of the present study were to determine the cardiovascular effects of arachidonic acid (AA) and to investigate the peripheral mechanisms mediating these effects in haemorrhage-induced hypotensive rats. 2. Acute haemorrhage was induced by withdrawing a total volume of 2.2 mL blood/100 g bodyweight over a period of 10 min. Rats were then injected with 75-300 mu g, i.c.v., AA and cardiovascular changes were monitored over the next 60 min. Plasma catecholamine and vasopressin levels, as well as plasma renin activity (PRA), were measured 10 min after injection of 150 mu g AA in haemorrhage-induced hypotensive awake rats. In addition, rats were pretreated with saline (1 mL/kg, i.v.), the vasopressin V-1 receptor antagonist [beta-mercapto-beta,beta-cyclopentamethylenepropionyl(1),O-Me-Tyr(2),Arg(8)]-vasopressin (10 mu g/kg, i.v.), the alpha(1)-adrenoceptor antagonist prazosin (500 mu g/kg, i.v.), the non-specific angiotensin II receptor antagonist saralasin (250 mu g/kg, i.v.) or a combination of these three antagonists 5 min before injection of AA (150 mu g, i.c.v.). The effects of these antagonists on responses to AA were determined. 3. Arachidonic acid caused dose- and time-dependent increases in mean arterial pressure and heart rate and reversed hypotension in haemorrhaged rats. Haemorrhage itself produced an increase in plasma catecholamine and vasopressin levels, as well as PRA; injection of AA produced further increases in these parameters, ranging from 39-123%, under hypotensive conditions. Under hypotensive conditions, pretreatment of rats with all three receptor antagonists produced similar partial blockade of the pressor response to AA, but not the increase in heart rate. Moreover, combined administration of all three receptor antagonists prior to the i.c.v. injection of 150 mu g AA completely abolished the pressor response to AA in haemorrhage-induced hypotensive rats. 4. These results indicate that centrally administered AA reverses hypotension by increasing blood pressure and heart rate in the hypotensive setting. The observed increases in plasma catecholamine and vasopressin levels, as well as PRA, mediate the pressor response to AA in haemorrhage-induced hypotensive rats. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Alpha (1)-adrenoreceptor | en_US |
dc.subject | Angiotensin II receptors | en_US |
dc.subject | Arachidonic acid | en_US |
dc.subject | Catecholamine | en_US |
dc.subject | Hypotension | en_US |
dc.subject | Intracerebroventricular | en_US |
dc.subject | Renin activity | en_US |
dc.subject | V 1 receptors | en_US |
dc.subject | Vasopressin | en_US |
dc.subject | Sympatho-adrenomedullary outflow | en_US |
dc.subject | Central cholinergic system | en_US |
dc.subject | Normotensive conscious rats | en_US |
dc.subject | Blood-flow autoregulation | en_US |
dc.subject | Thromboxane a2 analog | en_US |
dc.subject | Newborn pigs | en_US |
dc.subject | Vasopressin secretion | en_US |
dc.subject | Cerebral-circulation | en_US |
dc.subject | Injected u-46619 | en_US |
dc.subject | Activation | en_US |
dc.subject | Pharmacology & pharmacy | en_US |
dc.subject | Physiology | en_US |
dc.subject.mesh | Adrenergic alpha-1 receptor antagonists | en_US |
dc.subject.mesh | Angiotensin receptor antagonists | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Arachidonic acid | en_US |
dc.subject.mesh | Blood pressure | en_US |
dc.subject.mesh | Cardiovascular system | en_US |
dc.subject.mesh | Catecholamines | en_US |
dc.subject.mesh | Consciousness | en_US |
dc.subject.mesh | Drug evaluation, preclinical | en_US |
dc.subject.mesh | Heart rate | en_US |
dc.subject.mesh | Hemorrhage | en_US |
dc.subject.mesh | Hormone antagonists | en_US |
dc.subject.mesh | Hypotension | en_US |
dc.subject.mesh | Injections, intraventricular | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Rats | en_US |
dc.subject.mesh | Rats, sprague-dawley | en_US |
dc.subject.mesh | Receptors, vasopressin | en_US |
dc.subject.mesh | Signal transduction | en_US |
dc.subject.mesh | Vasopressins | en_US |
dc.title | Cardiovascular effects of centrally administered arachidonic acid in haemorrhage-induced hypotensive rats: Investigation of a peripheral mechanism | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000265549100015 | tr_TR |
dc.identifier.scopus | 2-s2.0-68849095950 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Veteriner Fakültesi/Fizyoloji Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-5600-8162 | tr_TR |
dc.contributor.orcid | 0000-0002-3090-0099 | tr_TR |
dc.identifier.startpage | 447 | tr_TR |
dc.identifier.endpage | 453 | tr_TR |
dc.identifier.volume | 36 | tr_TR |
dc.identifier.issue | 4 | tr_TR |
dc.relation.journal | Clinical and Experimental Pharmacology and Physiology | en_US |
dc.contributor.buuauthor | Yalçın, Murat | - |
dc.contributor.buuauthor | Aydın, Cenk | - |
dc.contributor.researcherid | AAG-6956-2021 | tr_TR |
dc.identifier.pubmed | 19702598 | tr_TR |
dc.subject.wos | Pharmacology & pharmacy | en_US |
dc.subject.wos | Physiology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | Pubmed | en_US |
dc.wos.quartile | Q3 | en_US |
dc.contributor.scopusid | 57192959734 | tr_TR |
dc.contributor.scopusid | 7005426982 | tr_TR |
dc.subject.scopus | Histamine H4 Receptors; Thioperamide; Chlorpheniramine Maleate | en_US |
dc.subject.emtree | Adrenalin | en_US |
dc.subject.emtree | Alpha 1 adrenergic receptor blocking agent | en_US |
dc.subject.emtree | Angiotensin 2 receptor antagonist | en_US |
dc.subject.emtree | Arachidonic acid | en_US |
dc.subject.emtree | Argipressin[1 (3,3 cyclopentamethylene 3 mercaptopropionic acid) 2 (o methyltyrosine)] | en_US |
dc.subject.emtree | Catecholamine | en_US |
dc.subject.emtree | Noradrenalin | en_US |
dc.subject.emtree | Prazosin | en_US |
dc.subject.emtree | Saralasin | en_US |
dc.subject.emtree | Vasopressin | en_US |
dc.subject.emtree | Adrenalin blood level | en_US |
dc.subject.emtree | Animal experiment | en_US |
dc.subject.emtree | Animal model | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Cardiovascular effect | en_US |
dc.subject.emtree | Catecholamine blood level | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Dose response | en_US |
dc.subject.emtree | Heart rate | en_US |
dc.subject.emtree | Hemorrhagic shock | en_US |
dc.subject.emtree | Hypotension | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Mean arterial pressure | en_US |
dc.subject.emtree | Nonhuman | en_US |
dc.subject.emtree | Noradrenalin blood level | en_US |
dc.subject.emtree | Plasma renin activity | en_US |
dc.subject.emtree | Pressor response | en_US |
dc.subject.emtree | Rat | en_US |
dc.subject.emtree | Vasopressin blood level | en_US |
dc.subject.emtree | Statistical analysis | en_US |
Koleksiyonlarda Görünür: | Scopus Web of Science |
Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.
DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.